Abstract
In this study alterations are characterized which occur, in myocardial force development morphological appearance and protein composition, during the development of cardiac hypertrophy and heart failure in monocrotaline (MCT) treated rats. The transition from cardiac hypertrophy to heart failure was studied by comparing the results from control (CON) and two MCT groups (40 and 44 mg/kg body weight). The three experimental groups consisted of at least five animals each. Parameters studied were: body weight (measured daily), lung/body weight ratio, right ventricular wall volume and thickness, and force development in thin right ventricular trabeculae at 27°C, using different extracellular calcium concentrations and pacing frequencies. MCT injection resulted in marked right ventricular hypertrophy and heart failure as evidenced by an up to 2-fold increase in lung/body weight ratio and a 1.7-fold increase in wall volume. The MCT groups showed a negative force–frequency relation and maximum force was up to 2-fold less than in the CON group. Protein analysis by means of one- and two-dimensional gel electrophoresis revealed a marked (7-fold) up-regulation of the slow myosin heavy chain isoform as well as a 4.5-fold increase in the content of the cytoskeletal protein desmin, whereas the mitochondrial protein ATP-synthase content was reduced. Hence MCT-induced cardiac hypertrophy and heart failure result in altered cellular calcium handling, depression of maximum force output, an increase in the economy of myocardial contraction and changes in cytoskeletal structure and energy supply.
Similar content being viewed by others
References
Fan DT, Wannenburg T and de Tombe PP (1997) Decreased myocyte tension development and calcium responsiveness in rat right ventricular pressure overload. Circulation 95: 2312–2317.
Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H and Drexler H (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434–442.
Hasenfuss G, Schillinger W, Lehnart SE, Preuss M, Pieske B, Maier LS, Prestle J, Minami K and Just H (1999) Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99: 641–648.
Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klovekorn WP, Schaper M, Schaper W and Schaper J (2000) Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86: 846–853.
Hislop A and Reid L (1974) Arterial changes in Crotalaria spectabilisinduced pulmonary hypertension in rats. Br J Exp Path 55: 153–163.
Ingwall JS (1993) Is cardiac failure a consequence of decreased energy reserve? Circulation 87(suppl VII): VII-58-VII-62.
Katz AM (1990) Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322: 100–110.
Keith M, Geranmaygan A, Sole MJ, Kurian R, Robinson A, Omran AS and Jeejeebhoy KN (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31: 1352–1356.
Loud Av and Anversa P (1984) Biology of disease: morphometric analysis of biologic processes. Lab Invest 50: 250–261.
Mathew R, Gloster ES, Sundarajan T, Thompson CI, Zeballos GA and Gewitz MH (1997) Role of inhibition of nitric oxide production in momcrotaline-induced pulmonary hypertension. J Appl Physiol 82: 1493–1498.
Mitani Y, Maruyama K and Sakurai M (1997) Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96: 689–697.
Mulieri LA, Hasenfuss G, Ittleman F, Blanchard EM and Alpert NR (1989) Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res 65: 1441–1449.
Mulieri LA, Hasenfuss G, Leavitt B, Allen PD and Alpert NR (1992) Altered myocardial force-frequency relation in human heart failure. Circulation 85: 1743–1750.
Opie LH (1998) The Heart: Physiology, From Cell to Circulation. Lippincott Raven Publishers, Philadelphia, USA.
Papp Z, van der Velden J and Stienen GJM (2000) Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes from rat heart. Cardiovasc Res 45: 981–993.
Parmley WW (1992) Pathophysiology of congestive heart failure. Clin Cardiol 15(suppl 1): 15–112. Ruijter W de, Stienen GJM, Klarenbosch J van and Lange JJ de (2002) Positive and negative e.ects of propofol via L-type calcium channels and the sodium-calcium exchanger in rat cardiac trabeculae Anaesthesiology (in press).
Tombe AL des, Beek-Harmsen van BJ, Lee-de Groot MBE and Laarse WJ van der (2002) Calibrated histochemistry applied to oxygen supply and demand in hypertrophied rat myocardium. Micr Res Tech (in press).
Velden J van der, Klein LJ, Zaremba R, Boontje NM, Huybregts MAJM, Stooker W, Eijsman L, Jong JW de, Visser CA, Visser FC and Stienen GJM (2001) Effects of inorganic phosphate and pH on isometric force development in single skinned cardiomyocytes from donor and failing human hearts. Circulation 104: 1140–1146.
Wilson DW, Segall HJ, Pan LC, Lame MW, Estep JE and Morin D (1992) Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit Rev Toxicol 22: 307–325.
Wu Y, Cazorla O, Labeit D, Labeit S and Granzier H (2000) Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J Mol Cell Cardiol 32: 2151–2162.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Korstjens, I., Rouws, C., Van Der Laarse, W. et al. Myocardial force development and structural changes associated with monocrotaline induced cardiac hypertrophy and heart failure. J Muscle Res Cell Motil 23, 93–102 (2002). https://doi.org/10.1023/A:1019988815436
Issue Date:
DOI: https://doi.org/10.1023/A:1019988815436